In our search for candidate genes for affective disorder on the short arm of chromosome 18, we cloned IMPA2, a previously unreported myo-inositol monophosphatase gene, that maps to 18p11.2. We determined its genomic structure and detected three new single nucleotide polymorphisms (SNPs). In the present study, we screened the gene further to search for additional polymorphisms in Japanese samples and identified seven other SNPs, including a novel missense mutation. These polymorphisms clustered into three regions of the gene. Three relatively informative SNPs, 58GϾA, IVS1-15GϾA and 800CϾT from clusters 1, 2 and 3, respectively, were selected for association tests using a case-control design. The Japanese cohort included 302 schizophrenics, 205 patients with affective disorder and 308 controls. Genotyping was done either by melting curve analysis on the LightCycler or by sequencing. All three SNPs showed significant genotypic association (nominal P = 0.031-0.0001) with schizophrenia, but not with affective disorder. These findings increase the relevance of 18p11.2 to schizophrenia susceptibility because GNAL, which has been shown previously to be implicated in schizophrenia in an independent study, is in close physical proximity to IMPA2. Our findings suggest that IMPA2 or a gene nearby may contribute to the overall genetic risk for schizophrenia among Japanese. Molecular Psychiatry (2001) 6, 202-210.
Introduction
Recent linkage findings have revealed overlapping chromosomal regions for mood disorders and schizophrenia. 1, 2 The centromeric portion of chromosome 18 has been proposed to encode a susceptibility locus for bipolar disorder 3 and this has been supported by other studies. 4, 5 Extension of the analysis on chromosome 18 using closely-spaced markers localized the maximal peak of excess allele sharing on 18p11.2.
1 A prior linkage and association study has implicated the same region in schizophrenia. 6 We have previously isolated transcripts mapping to chromosome 18 through cDNA selection. 7 In our search for candidate genes mapping to 18p11.2, we cloned a gene encoding a second human myo-inositol monophosphatase (IMPA2). 8 IMPA2 may be considered a functional candidate gene because of its presumed involvement in the phospholipase C signalling pathway, through which the action of multiple neurotransmitters and hormones is mediated. It is therefore possible that a variant (s) in a component of this pathway may correlate with susceptibility to mental illness. In addition, the enzyme has been shown to be inhibited by lithium, a potent therapeutic and prophylactic drug for mood swings. 9 An abnormality of inositol availability has been suggested also in schizophrenia psychopathology. 10 Support for 18p11.2 as a susceptibility locus in functional psychoses has been found in schizophrenia families which included family members with affective disorder. 6 A significant association with GNAL (G-olf␣) has been reported. In an earlier study, we found that GNAL and IMPA2 are in close physical proximity. 11 These lines of evidence provide a basis for scrutinizing the possible etiologic role of IMPA2 in mood disorders and schizophrenia.
To permit screening for sequence variations in the entire IMPA2 gene, we determined the exon-intron structure and cloned the 5Ј flanking sequence of IMPA2. 11 In our initial survey using 22 unrelated affected individuals from multiplex Caucasian bipolar pedigrees, 12 we identified a His76Tyr (468CϾT) missense mutation in exon 2, an RsaI polymorphism (IVS1−15GϾA) in intron 1, and an SNP, 401TϾC (Leu53Leu) in exon 2. 11 In the present study we detected additional polymorphisms and performed association tests using a case-control paradigm. Here, we present evidence for association with schizophrenia but not with affective disorder in Japanese samples.
Materials and methods

Patients and controls
Mood disorder patients met the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), and were diagnosed as either unipolar or bipolar based on interviews by, and consensus of, at least two experienced psychiatrists. Patients were identified in both inpatient and outpatient clinics. Medical records and all other available information were also referred for diagnosis. The unipolar patients consisted of 42 males, ages 27-74 years (mean 53 ± 14 years), and 58 females, ages 20-83 years (mean age 58 ± 13 years). Fifty-nine percent of the unipolar patients had recurrent episodes of depression. The bipolar patients consisted of 59 males, ages 22-77 years (mean 50 ± 9 years), and 46 females, ages 27-75 years (mean 51 ± 13 years). Of 105 bipolar patients, 63 subjects have bipolar I and the others have bipolar II. Schizophrenia patients were chosen based on the DSM-IV criteria from both outpatients and inpatients. There were 166 males, ages 21-80 years (mean 46 ± 13 years), and 136 females, ages 21-75 years (mean 46 ± 13 years). Control subjects were recruited from hospital staff documented to be free of psychoses, and company employees who did not manifest psychiatric problems in brief interviews by psychiatrists. They included 160 males (mean 46 ± 9 years) and 148 females (mean 44 ± 15 years). The present study was approved by the Ethics Committees of RIKEN and Tokyo Medical and Dental University, and all participants gave informed consent.
Screening for the 468CϾT (His76Tyr) missense polymorphism
In this study, the nucleotide positions in the cDNA sequence are expressed by base counts from nt 1 at the cap site. 11 The first nucleotide of the initiation codon corresponds to nt 242.
Genomic DNA was extracted using the DNA Extraction kit (Stratagene, La Jolla, CA, USA). To introduce the Tsp45I restriction site for the wild-type sequence, we used a modified upstream PCR primer, 5Ј-GTTGCGAGAGAGGTTTCCGTCA (5Ј end at nt 446, the underlined G was used instead of the authentic T), and an authentic downstream primer, 5Ј-Molecular Psychiatry CCACATCAACAAACAGCAGAGC (5Ј end at nt IVS2+102). These primers amplified a 129-bp product. PCR was performed with an initial 1-min denaturation at 94°C, followed by 30 cycles of 94°C for 15 s, 55°C for 30 s, 72°C for 1 min, and a final extension period at 72°C for 5 min, using Ex Taq (Takara, Tokyo, Japan) and the GeneAmp PCR System 9700 thermocycler (PE Applied BioSystems, Norwalk, CT, USA). A 20-l aliquot of the amplified mixture was incubated with 0.8 unit of Tsp45I (New England Biolabs, Beverly, MA, USA) for 2 h, and then separated on a 2% Nusieve 3:1 agarose gel. The restriction patterns were confirmed by sequencing.
Mutation scanning of the IMPA2 gene by sequencing
The primer sets and DNA polymerase/buffer combinations that were used in screening for mutation or polymorphisms are listed in Table 2 of our previous paper. 11 In addition, for the screening of the 5Ј-upstream region, the following two primer sets were used: (1) (F) 5Ј-ACCCAGAACAGTACGGAGTTCT (5Ј end at 525 bp upstream to exon 1); (R) 5Ј-ACCCGTTGCTGCTCCTG GCCT (5Ј end at 139 bp upstream to exon 1). PCR was done using Ex Taq (Takara) and MasterAmp D buffer (Epicentre, Madison, WI, USA). (2) (F) 5Ј-CACTGATTTGTGTTCAGGGCTA (5Ј end at 264 bp upstream to exon 1); (R) 5Ј-GTCC TGCTTTCCGCTCCCCA (5Ј end at nt 36 in exon 1). To amplify this region, the Expand System (buffer 3) from Boehringer Mannheim (Mannheim, Germany) was used. All PCR reactions were done with the annealing temperature set at 55°C. Sequencing of the PCR product was conducted using the BigDye terminator cycle sequencing kit (PE Applied BioSystems) on an ABI 377 DNA sequencer (PE Applied BioSystems). Confirmation of polymorphisms was done by dye-terminator sequencing from both directions and/or by using the BigDye primer cycle sequencing kit (−21M13) (PE Applied BioSystems).
Genotyping at the IVS1−15GϾA locus Genomic DNA was amplified by using the upstream primer, 5Ј-TGGGAGGAGGATGTTTGCATG (5Ј end at nt IVS1−51) and the downstream primer, 5Ј-CTGC ATTCTCTATGAGTGTGG (5Ј end at nt IVS2+61), and by using Ex Taq (Takara). Samples that were not successfully amplified were not included in the genotype count. Analysis of IVS1-15GϾA was initially performed by using the restriction enzyme, RsaI. However, some of seemingly heterozygous patterns turned out to be homozygous when checked by the dye primer sequencing method. This complication was probably due to incomplete digestion. We therefore introduced a melting curve analysis using the LightCycler ™ that utilizes a fluorescence resonance energy transfer (FRET)-based approach. 13 By using this method in a prior study, 13 we were able to score a DUSP6 gene SNP reliably and efficiently. The details of this method are described elswhere. 13 Briefly, the procedure consists of monitoring the melting curve profile produced by incubating a target PCR fragment with two fluorescence-lab-elled primers, a detection probe and an anchor probe. The detection probe is a polymorphism-detection primer, which spans the polymorphic site, and is labelled on the 3Ј-end with fluorescein, a donor fluorophore. The second primer is an anchor probe located in close proximity to the detection probe and is labelled with the acceptor fluorophore LightCycler RED 640 (LC-RED) at the 5Ј-end. Fluorescein is excited by the LED light source and emits light at a wavelength that excites the acceptor fluorophore. The acceptor fluorophore then emits light of a longer wavelength that can be measured by an optical unit.
Continuous fluorescence monitoring of the reaction as the temperature is raised from annealing to denaturation results in a sharp decrease in fluorescence at the temperature at which the detection probe dissociates from the template. In this study the detection probe was a 25-mer oligonucleotide, labelled at the 3Ј-end with FITC. The sequence was 5Ј-AACCCAAA TCCCGTACTTTTATTTC (based on the sense strand), with the polymorphic site at the 13th nucleotide from the 5Ј-end (underlined nt). The anchor probe was 5Ј-LC-RED labelled 29-mer, 5Ј-CATCAGAAAAGCCCTTA CTGAGGAAAAAC, the 3Ј-end of which was phosphorylated to block extension by Taq polymerase. The 5Ј-end of the anchor probe was located five nucleotides downstream of the 3Ј-end of the detection probe. Both fluorophore-labelled probes were synthesized and purified by reverse-phase HPLC by Nihon Gene Research Labs, Japan.
Fluorescence was measured continuously during the slow temperature rise after the probe hybridization to monitor the dissociation of the FITC-labelled detection probe. The fluorescence signal (F) was plotted in realtime against temperature (T) to produce melting curves for each sample (F vs T). Melting curves were then converted to melting peaks by plotting the negative derivative of the fluorescence with respect to temperature against temperature (−dF/dT vs T).
Genotyping at the 800CϾT locus Genomic DNA was amplified using the upstream primer, 5Ј-GAAGAGGCCAGGAGCAGCAACGGGT (5Ј end at nt IVS7-77) and the downstream primer, 5Ј-GGTAGCCAGGAGCAGAGCGTGA (5Ј end at 116 bp downstream to the stop codon). Genotyping was done by using the FRET approach as above. The detection probe was 5Ј-CCCTGAAGCTGTTCCTGAGTA-FITC (based on the sense strand) (the polymorphic site is underlined). The anchor probe was 5Ј-LC-RED-CATGGAGCGGCTGCTGCATG and the 3Ј-end was phosphorylated. The 5Ј-end of the anchor probe was located two nucleotides downstream of the 3Ј-end of the detection probe. Melting curve analysis was performed as above.
Genotyping at the 58GϾA locus Genomic DNA was amplified using the upstream primer, 5Ј-AGGCCAGGAGCAGCAACGGGT 5Ј end at nt −159) and the downstream primer, 5Ј-TGTGCCTG CTCCCGCAGCTCTGT (5Ј end at nt 145), under the same cycling conditions as above, with the Expand enzyme (Boehringer Mannheim) and MasterAmp DN buffer (Epicentre). Genotyping was performed by sequencing the PCR products using the dGTP BigDye terminator cycle sequencing kit (PE Applied BioSystems) on either ABI 377 or ABI 3700 DNA sequencer (PE Applied BioSystems).
Genotyping of other polymorphic markers
The genotyping of all the other loci was done by sequencing to evaluate allele frequencies, linkage disequilibrium between markers, and haplotype frequencies.
Statistical analyses
Tests for Hardy-Weinberg equilibrium and allele comparisons were conducted by the use of 2 statistics with the significance level set at 5%. Differences of genotype and haplotype distributions between patient and control groups were first assessed by the Monte Carlo method using the CLUMP program with 10 000 simulations.
14 Empirical P-values calculated by the normal 2 × n 2 statistics in the program are shown in the result tables. When these P-values were less than 0.05, 2 × 2 2 analysis was applied to compare each genotype (haplotype) against the rest between patients and controls. Odds ratios (OR) with 95% confidence intervals were estimated for the effects of high-risk alleles and genotypes. The Cochran-Armitage linearity tendency test 15 (http://aoki2.si.gunma-u.ac.jp/lecture/Hiritu/ Armitage.html) was used to identify any dose effect of a susceptibility allele. Linkage disequilibrium (LD) between two loci and estimates of haplotype frequencies were assessed by using the Arlequin software 16 (http://anthropologie.unige.ch/arlequin/ methods.html).
Results
Screening for the His76Tyr missense mutation in Japanese samples
Since His76 is conserved in the vertebrate myo-inositol monophosphatase (IMP) family 8 and the His76Tyr substitution introduces a new functional group, the functional implications would be interesting. We therefore screened for the presence of the His76Tyr (468CϾT) missense mutation 11 in 360 Japanese subjects consisting of 120 normal controls, 120 patients with mood disorders and 120 schizophrenics (Table 1) . This mutation was not detected in these samples confirming our prior finding in Caucasian samples 11 that this substitution is extremely rare.
Polymorphisms found in Japanese
Next, we systematically screened the IMPA2 gene for additional polymorphisms by using 26-38 randomly selected individuals from affective disorder, schizophrenia and control groups. All exons, splice boundaries and the potential promoter region extending up to 525 bp upstream of the cap site were sequenced. This analysis detected seven additional polymorphic sites: In this study, we designated the introns as 1, 2, 3, -, instead of A, B, C, -as in the previous study.
11
−466GϾA, −219CϾT, 58GϾA, IVS5+13−14insA, 784CϾT (Ala181Val), 800CϾT, 1079CϾG (Table 1 , Figure 1 ). The IVS1−15GϾA, 401TϾC and IVS5+13−14insA polymorphic sites have been described recently also by Sjoholt et al. 17 All three seemed to have a higher heterozygosity in Japanese than in Caucasians. 11, 17 The 784T (Va1181) is a rare novel missense mutation but only one heterozygote out of 36 schizophrenics was identified (Table 1 ). This mutation was not examined in additional samples for the following reasons: the replacement of Ala by Val does not induce polarity change, the position is not conserved among the IMPs from different species 8 and the site is not involved in either metal binding or catalytic activity. 18 Position 1079 was occupied by a 'G' in the Japanese samples studied here and in the cohort examined by Sjoholt et al, 17 in contrast to 'C' in the samples used in our prior study. 
Figure 1
Genomic structure and locations of polymorphic sites of the IMPA2 gene. The 468T and 1079C were not detected in the present study. The other polymorphisms are divided into three regional clusters (see text). *These polymorphisms have been already reported in our previous study.
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Linkage disequilibrium (LD) analysis between markers on IMPA2
The polymorphic sites detected in this study can be grouped into three regional clusters, with each cluster spanning several kb (Figure 1 ). Cluster 1 included −466GϾA, −219CϾT and 58GϾA, cluster 2 consisted of IVS1−15GϾA and 401TϾC, and cluster 3 comprised IVS5+13−14insA, 784CϾT and 800CϾT. LD analysis was conducted between markers within each cluster and markers in different clusters by using available genotype data. We found that the two markers in cluster 2 (IVS1−15GϾA and 401TϾC) (P = 0.02) and the two markers in cluster 3 (IVS5+13−14insA and 800CϾT) (P Ͻ 0.001) were in linkage disequilibrium (Table 2) . In cluster 1, significant LD was observed between the polymorphic sites −466GϾA and −219CϾT (P = 0.004), and markers −219CϾT and 58GϾA (P = 0.004), but markers −466GϾA and 58GϾA within this cluster were not in LD (Table 2) , Data were analyzed by using the Arlequin software. 16 n is the number of samples used for calculation. D values indicate deviation from linkage equilibrium (D = h-p1p2; h, haplotype frequency; p1, p2, frequencies of two alleles at two loci). DЈ (= D/D max ) is the normalized linkage disequilibrium statistic, which lies in the range {0,1} with the greater value indicating stronger linkage disequilibrium. which may be due to a lack of power because of small sample size. Because of the existence of LD within individual clusters, we selected one marker from each cluster for subsequent association tests: 58GϾA from cluster 1, IVS1−15GϾA from cluster 2 and 800CϾT from cluster 3.
Melting curve analysis of the IVS1−15GϾA (cluster 2) polymorphism
In this study a small fraction of the samples from different groups could not be successfully amplified, therefore these samples were not included in the calculations. Because a conventional RFLP method did not produce unambiguous digestion patterns, we adopted a FRET-based approach 13 using the Light Cycler. Based on our experience this method has the advantage of ease, speed, accuracy and reproducibility. 13 The melting of the sample homozygous for A/A produced a rapid decrease in fluorescence between 60-61°C (Figure 2a1 ). In contrast, the melting of the G/G homozygote occurred between 65-66°C. The heterozygous sample exhibited two distinct decreases in fluorescence, corresponding to the presence of amplicons derived from both alleles. The peak of −dF/dT vs T for the A/A allele was detected at 61°C (Figure 2a2 ), whereas the sample homozygous for the G/G allele produced a melting peak at 65°C (the G allele perfectly matched the detection probe sequence). The heterozygous sample contained both types of targets and thus generated both peaks. The genotypes found by melting curve analysis corresponded to those obtained by dye primer sequencing (data not shown), confirming the accuracy of the LightCycler method.
The genotype and allelic distributions of the IVS1−15GϾA polymorphism obtained by melting curve analysis are shown in Table 3 . In mood disorder patients, the genotypic frequencies analyzed by the Monte Carlo method did not differ from those of controls, even when the unipolar and bipolar groups were analyzed separately. The genotypic frequencies in the mood disorder groups and controls were in Hardy- Likewise, allele frequencies in the combined mood disorder sample did not differ significantly from those of controls. This lack of association is consistent with our findings on Caucasian samples with affective disorder. 11 However, the genotypic frequencies in schizophrenics and controls were significantly different (nominal P = 0.030). A significantly greater percentage of schizophrenics (54%) vs controls (45%) had the G/G genotype (P = 0.036, 2 = 4.4, df = 1, OR = 1.41).
Melting curve analysis of the 800CϾT (cluster 3) polymorphism
We conducted another case-control comparison using the 800CϾT silent mutation (Phe178Phe) in exon 6, included in cluster 3, by genotyping using melting curve analysis (Figure 2b1 and 2b2) . The genotypic and allelic frequencies in the mood disorder samples did not deviate significantly from those of controls (Table  3 ). The genotype counts of the mood disorder and control groups were all in Hardy-Weinberg equilibrium (P = 0.42 for unipolars; P = 0.15 for bipolars; P = 0.39 for the combined affective disorder samples; P = 0.45 for controls). By contrast, in schizophrenia Monte Carlo simulations showed a significant genotypic association with this polymorphism (P = 0.0001). A markedly higher occurrence of the C/C genotype in the schizophrenic group compared to the control group was found (P = 0.0001, 2 = 15.1, df = 1, OR = 2.93).
Sequence analysis of the 58GϾA (cluster 1) polymorphism
We analyzed the 58GϾA polymorphism positioned within the 5Ј-upstream portion of the IMPA2 gene that is GC-rich and has multiple Sp1-binding motifs. The gene possibly utilizes more than one transcription start site. 11 Due to the high GC content of the region flanking the 58GϾA site, optimal probes for the melting curve analysis could not be designed. The restriction enzyme HhaI which could potentially resolve the 58GϾA polymorphism, generated ambiguous digestion patterns. We, therefore, typed this polymorphism through dGTP BigDye-terminator sequencing (Figure 3) . Table 3 shows the genotypic and allelic distributions in each group. A nominally significant genotypic association with schizophrenia (P = 0.031) but not with mood disorders was noted. The schizophrenia sample displayed a significantly greater number of A/A (P = 0.017, 
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LD analysis between clusters and haplotype analysis
To investigate the possible presence of LD between clusters, the genotypic data of 58GϾA in cluster 1, IVS1−15GϾA in cluster 2 and 800CϾT in cluster 3 were each analyzed in control and schizophrenia samples ( Table 2 ). Evidence of strong LD was obtained between the cluster 1 marker, 58GϾA and cluster 2 marker, IVS1−15GϾA. There was no LD between cluster 1 markers and the 800CϾT polymorphism in cluster 3. Similarly, there was no evidence of LD between cluster 2 and cluster 3 markers. These results suggest the occurrence of more frequent meiotic recombinations between clusters 2 and 3 than between clusters 1 and 2.
Haplotype frequencies defined by the 58GϾA, IVS1−15GϾA and 800CϾT were determined ( Table 4) . The haplotype distributions were significantly different in the control and schizophrenia groups (P = 0.005). However, no single haplotype was significantly overrepresented in the schizophrenia cohort compared with the control group. When the haplotypes were divided into those that have either 58A, IVS1−15G or 800C, and the haplotype that did not (ie GAT Figure 3 Genotyping of the 58GϾA polymorphism by sequencing. Sequencing was done using the cycle sequencing kit developed for GT-rich templates (see Materials and methods). 
G/G G/A A/A
Discussion
To investigate whether IMPA2 exerts a role in susceptibility to mood disorder or schizophrenia, association tests using a case-control paradigm were conducted. First, we screened the entire gene by sequencing randomly selected samples and this led to the detection of seven additional polymorphic sites including one novel missense substitution (784CϾT: Ala181Va1). Combined with our previous finding, 11 a total of 10 SNPs in the IMPA2 gene were identified. These polymorphic sites mapped to three regional clusters. Secondly, we found that markers within a cluster were in LD, therefore one marker from each cluster was picked for subsequent association analyses.
Tests were conducted on Japanese cohorts that included Ͼ300 schizophrenics, Ͼ200 mood disorder patients and Ͼ300 controls. Nominally significant association with schizophrenia but not mood disorders was displayed by the three markers: 58GϾA (cluster 1), IVS1−15GϾA (cluster 2) and 800CϾT silent mutation in exon 6 (cluster 3). Applying Bonferroni corrections for the number of markers and diagnostic groups tested obliterates the significance on markers in clusters 1 and 2. In contrast, the 800CϾT genotypic and allelic associations remain significant (P = 0.0001 × 9 = 0.0009).
Initially, it was surprising that association was not evident with affective illness, as the rationale for the involvement of this gene in mood disorder might be stronger than in schizophrenia. However, this finding reinforces a prior evidence 6 for a prediposing locus for schizophrenia on 18p11.2. Schwab et al reported association of GNAL with schizophrenia in German Molecular Psychiatry and Israeli family cohorts. 6 Because our previous study indicated a close proximity of GNAL to IMPA2, 8 it is possible that either IMPA2, GNAL or a gene nearby is involved in conferring risk for schizophrenia.
A possible reason why association was not detected in mood disorder may be its smaller sample size, compared to the schizophrenia panel. Power analysis 19 revealed that the power for detecting a significant Pvalue (less than 0.05) using the IVS1-15GϾA genotype frequency in the present sample size is 0.62 in schizophrenia, whereas it is only 0.25 in mood disorder.
Cluster-to-cluster LD analysis reveals LD between clusters 1 and 2 which are separated by ෂ12 kb. However, no evidence for LD is found between clusters 1 and 3, which are ෂ28 kb apart, and between clusters 2 and 3 which are separated by a ෂ16 kb interval. A recent LD analysis using SNPs around the APOE region in late-onset Alzheimer disease showed that the disease is associated with several markers within 1 cM, but these markers are not necessarily in LD with each other. 20 The actual length of genomic stretches with detectable LD is assumed to depend upon the genomic region and history of target populations.
Based on simulations by Collins et al, 21 Ott proposed that at short distances (Ͻ150 kb), there are two clusters of haplotypes, one corresponding to low and another to high association between loci on a haplotype. 22 Although the findings presented here remain to be confirmed, it is tempting to speculate that the haplotype consisting of the 58A or IVS1-15G variant and the disease locus represents low association, and the haplotype consisting of 800C and the disease locus represents high association. Predicting the exact location of the susceptibility gene is formidable, and prior studies reveal that disequilibrium and physical distance do not correlate significantly when distance is Ͻ60 kb. 21, 22 Haplotype analysis does not reveal a single haplotype that is significantly more frequent in schizophrenics than in controls. Instead, the group of haplotypes that contained either the 58A, IVS1-15G or 800C shows a significantly higher occurrence in schizophrenics than in controls, compared to the other haplotype (58G-IVS1-15A-800T). This suggests that no single background haplotype is conserved that significantly associates with schizophrenia in the ෂ28 kb region of the IMPA2 gene, probably due to high recombination events and/or a complex feature of genome organization around the IMPA2 gene. To address these issues further, it would be necessary to conduct extensive analysis of very closely-spaced markers, test independent panels, and use a family-based paradigm for linkage disequilibrium tests.
